Gongin Precision Ind. Co., Ltd (TPEX:3178)

Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	310.64	231.57	346.99	332.99	179.74	152.59
Short-Term Investments	17.59	18.42	12.97	67.94	10.86	10.05
Cash & Short-Term Investments	328.22	250	359.96	400.93	190.6	162.63
Cash Growth	41.50%	-30.55%	-10.22%	110.35%	17.20%	134.11%
Accounts Receivable	265.68	265.81	314.48	337.94	305.05	250.57
Other Receivables	21.73	22.27	2.47	2.92	1.51	7.41
Receivables	287.4	288.08	316.94	340.86	306.56	257.98
Inventory	392.5	391.17	418.65	377.76	249.27	246.51
Prepaid Expenses	6.78	7.44	12.75	20.59	26.26	31.22
Other Current Assets	1.19	1.21	6.98	11.02	19.38	3.1
Total Current Assets	1,016	937.9	1,115	1,151	792.07	701.44
Property, Plant & Equipment	1,710	1,717	1,637	1,568	1,522	1,473
Other Intangible Assets	13.33	16.14	19.63	24.74	30.8	32.36
Long-Term Deferred Tax Assets	24.85	23.37	23.53	22.47	20.9	21.23
Other Long-Term Assets	33.23	62.33	65.78	43.23	38.16	37.98
Total Assets	2,830	2,756	2,861	2,810	2,404	2,266
Accounts Payable	63.17	89.53	74.62	101.94	70.45	65.03
Accrued Expenses	-	147.8	161.02	165.86	145.34	139.88
Short-Term Debt	205	95	95	222.9	118.38	80
Current Portion of Long-Term Debt	-	267.48	422.75	245.9	232.26	208.92
Current Portion of Leases	7.42	8.26	8.08	5.25	6.22	6.32
Current Income Taxes Payable	1.07	2.16	50.21	57.43	27.07	24.33
Current Unearned Revenue	0.11	1.78	3.22	8.51	0.49	0.53
Other Current Liabilities	392.28	25.86	24.66	41.38	16.27	16.12
Total Current Liabilities	669.05	637.87	839.58	849.17	616.48	541.12
Long-Term Debt	655.71	611.58	464.07	525.8	538.63	500.94
Long-Term Leases	239.5	199.93	204.55	146.22	148.45	154.17
Long-Term Unearned Revenue	-	12.89	5.01	5.46	-	-
Long-Term Deferred Tax Liabilities	32.75	33.54	32.75	32.75	32.75	32.75
Other Long-Term Liabilities	37.62	0.88	0.54	-	0.13	0.13
Total Liabilities	1,635	1,522	1,580	1,595	1,380	1,282
Common Stock	450.5	450.5	450.5	450.5	450.5	450.5
Additional Paid-In Capital	171.08	171.08	171.08	162.63	162.63	162.63
Retained Earnings	569.74	607.93	654.99	564.04	376.56	338.4
Comprehensive Income & Other	-1.53	-0.3	-0.74	-0.51	-0.74	-0.66
Total Common Equity	1,190	1,229	1,276	1,177	988.95	950.87
Minority Interest	5.45	5.59	4.64	38.42	34.82	33.44
Shareholders' Equity	1,195	1,235	1,280	1,215	1,024	984.31
Total Liabilities & Equity	2,830	2,756	2,861	2,810	2,404	2,266
Total Debt	1,108	1,182	1,194	1,146	1,044	950.35
Net Cash (Debt)	-779.41	-932.24	-834.49	-745.14	-853.35	-787.72
Net Cash Per Share	-17.39	-20.69	-18.51	-16.52	-18.94	-17.47
Filing Date Shares Outstanding	45.16	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.16	45.05	45.05	45.05	45.05	45.05
Working Capital	347.04	300.04	275.69	301.99	175.59	160.32
Book Value Per Share	26.35	27.29	28.32	26.12	21.95	21.11
Tangible Book Value	1,176	1,213	1,256	1,152	958.15	918.51
Tangible Book Value Per Share	26.05	26.93	27.88	25.57	21.27	20.39
Land	-	148.65	136.61	136.61	136.61	136.61
Buildings	-	578.7	574.17	573.17	569.94	566.9
Machinery	-	2,081	2,009	1,940	1,864	1,755
Construction In Progress	-	532.15	426.17	328.15	203.54	87.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.